Source: Abstracts. Conference titles: Congress of the European Hematology Association. Unidade: FCF
Subjects: HEMOCROMATOSE, ANEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CANÇADO, Rodolfo Delfini et al. Efficacy and safety of deferasirox in patients with iron overload secondary to hereditary hemochromatosis: preliminary results of a 1-YR prospective study. 2012, Anais.. The Hague: European Hematology Association, 2012. . Acesso em: 30 set. 2024.APA
Cançado, R. D., Bastos, R., Melo, M., Santos, P., Guerra-Shinohara, E. M., & Chiattone, C. S. (2012). Efficacy and safety of deferasirox in patients with iron overload secondary to hereditary hemochromatosis: preliminary results of a 1-YR prospective study. In Abstracts. The Hague: European Hematology Association.NLM
Cançado RD, Bastos R, Melo M, Santos P, Guerra-Shinohara EM, Chiattone CS. Efficacy and safety of deferasirox in patients with iron overload secondary to hereditary hemochromatosis: preliminary results of a 1-YR prospective study. Abstracts. 2012 ;[citado 2024 set. 30 ]Vancouver
Cançado RD, Bastos R, Melo M, Santos P, Guerra-Shinohara EM, Chiattone CS. Efficacy and safety of deferasirox in patients with iron overload secondary to hereditary hemochromatosis: preliminary results of a 1-YR prospective study. Abstracts. 2012 ;[citado 2024 set. 30 ]